Skip to main content
BSX
NYSE Life Sciences

Boston Scientific Cuts Full-Year EPS Outlook as China Pricing Pressure Extends Into 2027

Tom Rudovsky · Reported by Wiseek News
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$42.15
Mkt Cap
$61.491B
52W Low
$39.57
52W High
$105.65
52W Position info
6.5% above low
Off High info
60% below high
Rel. Volume info
3.6× avg
Market data snapshot near publication time

BSX is trading near its 52-week low of $39.57 (6.5% above the low) on elevated volume (3.6× avg).

Summary

Q3 sales came in at $5.138B, up 1.5%, with adjusted EPS of $0.73 versus $0.75 a year ago. The bigger news is the full-year cut: FY2026 adjusted EPS is now $3.16–3.18 with sales growth of about 4.25%, and Q4 guidance of $0.77–0.79 adjusted EPS sits well below the 84-cent consensus reported yesterday. Management says China pricing pressure will persist into 2027, and weakness in electrophysiology and Watchman may not be offset by Farapulse growth. The $14.5B Penumbra deal now closes in Q1 2027 after regulatory delays, and higher interest rates have raised financing costs, increasing the earnings drag. This follows the October 28 8-K reporting the quarter and the September 8 disclosure that the August cyberattack would materially hit 2026 results — the cyber hit is now layered on top of underlying China and EP softness.

At the time of this announcement, BSX was trading at $42.15 on NYSE in the Life Sciences sector, with a market capitalization of approximately $61.5B. The 52-week trading range was $39.57 to $105.65. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

BSX - Latest Insights

BSX
Nov 02, 2026, 5:54 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $44.16
Real-time Price: $44.06 info
Change: -$0.100 (-0.23%) info
Market Cap: $63.907B info
BSX
Nov 02, 2026, 5:26 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $44.24
Real-time Price: $44.06 info
Change: -$0.180 (-0.41%) info
Market Cap: $63.907B info
BSX
Oct 28, 2026, 10:52 AM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $42.11
Real-time Price: $44.06 info
Change: +$1.96 (+5%) info
Market Cap: $63.907B info
BSX
Oct 28, 2026, 6:34 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $42.85
Real-time Price: $44.06 info
Change: +$1.21 (+3%) info
Market Cap: $63.907B info
BSX
Oct 28, 2026, 6:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $45.39
Real-time Price: $44.06 info
Change: -$1.33 (-3%) info
Market Cap: $63.907B info